Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.

Dib RW, Hachem RY, Chaftari AM, Ghaly F, Jiang Y, Raad I.

BMC Infect Dis. 2018 Dec 13;18(1):656. doi: 10.1186/s12879-018-3584-9.

2.

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy.

Wilson Dib R, Chaftari AM, Hachem RY, Yuan Y, Dandachi D, Raad II.

Open Forum Infect Dis. 2018 Oct 1;5(10):ofy249. doi: 10.1093/ofid/ofy249. eCollection 2018 Oct.

3.

Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden.

Raad S, Chaftari AM, Hachem RY, Shah P, Natividad E, Cleeland CS, Rosenblatt J.

Expert Rev Med Devices. 2018 Aug;15(8):591-596. doi: 10.1080/17434440.2018.1500892. Epub 2018 Aug 1.

PMID:
30067125
4.

Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism.

Al Hamal Z, Jordan M, Hachem RY, Alawami HM, Alburki AM, Yousif A, Deshmukh P, Jiang Y, Chaftari AM, Raad II.

Medicine (Baltimore). 2016 Apr;95(14):e2691. doi: 10.1097/MD.0000000000002691.

5.

In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters.

Jamal MA, Hachem RY, Rosenblatt J, McArthur MJ, Felix E, Jiang Y, Tailor RC, Raad I.

Antimicrob Agents Chemother. 2015 Sep;59(9):5611-8. doi: 10.1128/AAC.00834-15. Epub 2015 Jun 29.

6.

Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use.

Jamal MA, Garoge K, Rosenblatt JS, Hachem RY, Raad II.

Antimicrob Agents Chemother. 2015 Aug;59(8):4397-402. doi: 10.1128/AAC.04956-14. Epub 2015 May 4.

7.

The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.

Debiane L, Hachem RY, Al Wohoush I, Shomali W, Bahu RR, Jiang Y, Chaftari AM, Jabbour J, Al Shuaibi M, Hanania A, Pravinkumar SE, Schuetz P, Raad I.

Crit Care Med. 2014 Dec;42(12):2500-7. doi: 10.1097/CCM.0000000000000526.

PMID:
25083975
8.

Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine.

Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II.

Antimicrob Agents Chemother. 2014;58(2):1179-82. doi: 10.1128/AAC.01959-13. Epub 2013 Oct 28.

9.

Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms.

Rosenblatt J, Reitzel R, Dvorak T, Jiang Y, Hachem RY, Raad II.

Antimicrob Agents Chemother. 2013 Aug;57(8):3555-60. doi: 10.1128/AAC.00229-13. Epub 2013 May 13.

10.

Urinary catheterization of male rabbits: a new technique and a review of urogenital anatomy.

Uthamanthil RK, Hachem RY, Gagea M, Reitzel RA, Borne AT, Tinkey PT.

J Am Assoc Lab Anim Sci. 2013 Mar;52(2):180-5.

11.

Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications.

Raad II, Chaftari AM, Al Shuaibi MM, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY.

Ann Oncol. 2013 Jul;24(7):1873-9. doi: 10.1093/annonc/mdt110. Epub 2013 Mar 21.

12.

Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies.

Al Shuaibi M, Bahu RR, Chaftari AM, Al Wohoush I, Shomali W, Jiang Y, Debiane L, Raad S, Jabbour J, Al Akhrass F, Hachem RY, Raad I.

Clin Infect Dis. 2013 Apr;56(7):943-50. doi: 10.1093/cid/cis1029. Epub 2013 Jan 3. Erratum in: Clin Infect Dis. 2013 Sep;57(5):779.

PMID:
23288950
13.

Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors.

Bahu R, Chaftari AM, Hachem RY, Ahrar K, Shomali W, El Zakhem A, Jiang Y, AlShuaibi M, Raad II.

J Urol. 2013 Jan;189(1):130-5. doi: 10.1016/j.juro.2012.08.094. Epub 2012 Nov 16.

PMID:
23164390
14.

Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.

Chaftari AM, Hachem RY, Ramos E, Kassis C, Campo M, Jiang Y, Prince RA, Wang W, Raad II.

Transplantation. 2012 Aug 15;94(3):302-8. doi: 10.1097/TP.0b013e3182577485.

PMID:
22814329
15.

Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.

Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY.

Antimicrob Agents Chemother. 2012 Feb;56(2):935-41. doi: 10.1128/AAC.05836-11. Epub 2011 Nov 28.

16.

Hospital environment and invasive aspergillosis in patients with hematologic malignancy.

Lee LD, Hachem RY, Berkheiser M, Hackett B, Jiang Y, Raad II.

Am J Infect Control. 2012 Apr;40(3):247-9. doi: 10.1016/j.ajic.2011.03.031.

PMID:
21856045
17.

Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients.

Chaftari AM, Kassis C, El Issa H, Al Wohoush I, Jiang Y, Rangaraj G, Caillouet B, Pravinkumar SE, Hachem RY, Raad II.

Cancer. 2011 Jun 1;117(11):2551-8. doi: 10.1002/cncr.25807. Epub 2010 Dec 14.

18.

Clinical experience of linezolid in bone marrow transplantation patients.

Hogan HL, Hachem RY, Neuhauser M, Raad II, Coyle E.

J Pharm Pract. 2010 Aug;23(4):352-7. doi: 10.1177/0897190009358773. Epub 2010 Mar 31.

PMID:
21507835
19.

The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.

Raad II, Mohamed JA, Reitzel RA, Jiang Y, Dvorak TL, Ghannoum MA, Hachem RY, Chaftari AM.

Biomaterials. 2011 Apr;32(11):2689-94. doi: 10.1016/j.biomaterials.2010.12.015. Epub 2011 Feb 3.

PMID:
21295343
20.

Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience.

Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II.

Crit Care Med. 2011 Feb;39(2):245-51. doi: 10.1097/CCM.0b013e3181feb83e.

PMID:
21057308
21.

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.

Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1387-94. doi: 10.1007/s10096-010-1013-0. Epub 2010 Aug 12.

PMID:
20703506
22.

Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?

Mihu CN, Kassis C, Ramos ER, Jiang Y, Hachem RY, Raad II.

Cancer. 2010 Nov 15;116(22):5290-6. doi: 10.1002/cncr.25312.

23.

Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.

Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad II.

Medicine (Baltimore). 2010 Jul;89(4):236-44. doi: 10.1097/MD.0b013e3181e9441b. Review.

24.

Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.

Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1265-71. doi: 10.1016/j.bbmt.2010.03.011. Epub 2010 Mar 18.

25.

Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study.

Chemaly RF, Hachem RY, Husni RN, Bahna B, Abou Rjaili G, Waked A, Graviss L, Nebiyou Bekele B, Shah JN, Raad II.

Ann Surg Oncol. 2010 Jun;17(6):1499-506. doi: 10.1245/s10434-010-0923-5. Epub 2010 Feb 3. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S330. Rjaili, Georges Abou [corrected to Abou Rjaili, Georges].

PMID:
20127184
26.

The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2.

Chemaly RF, Sharma PS, Youssef S, Gerber D, Hwu P, Hanmod SS, Jiang Y, Hachem RY, Raad II.

Int J Infect Dis. 2010 Jul;14(7):e548-52. doi: 10.1016/j.ijid.2009.08.007. Epub 2009 Dec 14. Review.

27.

Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods.

Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I.

J Clin Microbiol. 2009 Oct;47(10):3255-60. doi: 10.1128/JCM.01045-09. Epub 2009 Aug 19.

28.

Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution.

Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY.

Medicine (Baltimore). 2009 Jul;88(4):211-20. doi: 10.1097/MD.0b013e3181af01fc.

29.

Multidrug-resistant Escherichia coli bacteremia in cancer patients.

Vigil KJ, Adachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, Tarrand JJ, Chemaly RF, Bodey GP, Rolston KV, Raad I.

Am J Infect Control. 2009 Nov;37(9):741-5. doi: 10.1016/j.ajic.2009.02.002. Epub 2009 May 31.

PMID:
19487050
30.

Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens.

Reitzel RA, Dvorak TL, Hachem RY, Fang X, Jiang Y, Raad I.

Am J Infect Control. 2009 May;37(4):294-300. doi: 10.1016/j.ajic.2008.07.003. Epub 2009 Jan 19.

PMID:
19155100
31.

Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.

Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I.

J Clin Microbiol. 2009 Jan;47(1):129-33. doi: 10.1128/JCM.00506-08. Epub 2008 Nov 12.

32.

Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.

Hachem RY, Langston AA, Graybill JR, Perfect JR, Pedicone LD, Patino H, Raad II.

J Antimicrob Chemother. 2008 Dec;62(6):1386-91. doi: 10.1093/jac/dkn401. Epub 2008 Oct 3.

PMID:
18835806
33.

The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients.

Ghanem G, Hachem RY, Chemaly RF, Dvorak T, Hulten K, Graviss L, Raad II.

Am J Infect Control. 2008 Nov;36(9):656-60. doi: 10.1016/j.ajic.2008.03.007. Epub 2008 Oct 3.

PMID:
18834742
34.

Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm.

Raad II, Hachem RY, Hanna HA, Fang X, Jiang Y, Dvorak T, Sherertz RJ, Kontoyiannis DP.

Int J Antimicrob Agents. 2008 Dec;32(6):515-8. doi: 10.1016/j.ijantimicag.2008.06.020. Epub 2008 Sep 9.

PMID:
18783924
35.

Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer.

Hachem RY, Boktour MR, Hanna HA, Husni R, Hanna EY, Keutgen X, Shukrallah B, Raad II.

Infection. 2008 Dec;36(6):539-42. doi: 10.1007/s15010-008-7388-5. Epub 2008 Aug 25.

PMID:
18726553
36.

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.

Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II.

Cancer. 2008 Mar 15;112(6):1282-7. doi: 10.1002/cncr.23311.

37.
38.

Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy.

Lee LD, Berkheiser M, Jiang Y, Hackett B, Hachem RY, Chemaly RF, Raad II.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1066-70. Epub 2007 Jul 6.

PMID:
17932828
39.

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.

Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II.

Antimicrob Agents Chemother. 2007 Jun;51(6):1905-11. Epub 2007 Mar 26.

40.

Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP.

Clin Infect Dis. 2006 May 15;42(10):1398-403. Epub 2006 Apr 11.

PMID:
16619151
41.

Posaconazole: a broad-spectrum triazole antifungal.

Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II.

Lancet Infect Dis. 2005 Dec;5(12):775-85. Review.

PMID:
16310149
42.

Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm.

Raad II, Hanna HA, Boktour M, Chaiban G, Hachem RY, Dvorak T, Lewis R, Murray BE.

Antimicrob Agents Chemother. 2005 Dec;49(12):5046-50.

43.

Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology.

Raad II, Hanna HA, Boktour M, Jabbour N, Hachem RY, Darouiche RO.

Infect Control Hosp Epidemiol. 2005 Jul;26(7):658-61.

PMID:
16092749
44.

Cytomegalovirus pneumonia in patients with lymphoma.

Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II.

Cancer. 2005 Sep 15;104(6):1213-20.

45.

Multiple-species candidemia in patients with cancer.

Boktour MR, Kontoyiannis DP, Hanna HA, Hachem RY, Girgawy E, Bodey GP, Raad II.

Cancer. 2004 Oct 15;101(8):1860-5.

46.

Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.

Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad II.

Cancer. 2004 Oct 1;101(7):1594-600.

47.

Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, Rice LB.

Antimicrob Agents Chemother. 2004 Sep;48(9):3583-5.

48.

Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.

Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV.

Cancer. 2003 Sep 1;98(5):1039-47.

49.
50.

Evaluation of the silver iontophoretic catheter in an animal model.

Hachem RY, Wright KC, Zermeno A, Bodey GP, Raad II.

Biomaterials. 2003 Sep;24(20):3619-22.

PMID:
12809792

Supplemental Content

Loading ...
Support Center